Where does BCTG stock trade?

BCTG Acquisition Corp. (BCTG) is listed on NASDAQ.

What sector and industry is BCTG in?

BCTG Acquisition Corp. operates in the Finance sector, Business Services industry.

When did BCTG Acquisition Corp. go public?

BCTG Acquisition Corp. (BCTG) completed its IPO in 2020.

What companies are similar to BCTG?

Notable peers in the same industry include FLT (FleetCor Technologies Inc.), NVEI (Nuvei Corporation Subordinate Voting Shares), NLSN (Nielsen N.V.), STMP (Stamps.com Inc.), ENV (Envestnet Inc). Compare BCTG side-by-side with any of them on Quantisnow.

How can I track BCTG on Quantisnow?

Quantisnow aggregates BCTG Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BCTG to receive live email and push alerts on every new disclosure.

BCTG

NASDAQ

BCTG Acquisition Corp.

SectorFinanceIndustryBusiness ServicesIPO2020

$10.30-0.05 (-0.48%)

News25/Ratings0

Latest news

25 items

1697dSEC
SEC Form S-8 filed by BCTG Acquisition Corp.
S-8 - Tango Therapeutics, Inc. (0001819133) (Filer)
1704dSEC
SEC Form 424B3 filed by BCTG Acquisition Corp.
424B3 - Tango Therapeutics, Inc. (0001819133) (Filer)
1712dSEC
SEC Form EFFECT filed by BCTG Acquisition Corp.
EFFECT - Tango Therapeutics, Inc. (0001819133) (Filer)
1712dSEC
SEC Form 424B3 filed by BCTG Acquisition Corp.
424B3 - Tango Therapeutics, Inc. (0001819133) (Filer)
1731dSEC
SEC Form S-1 filed by BCTG Acquisition Corp.
S-1 - Tango Therapeutics, Inc. (0001819133) (Filer)
1731d13D/G
SEC Form SC 13G filed by BCTG Acquisition Corp.
SC 13G - Tango Therapeutics, Inc. (0001819133) (Subject)
1752dINSIDER
SEC Form 3: Boxer Capital, LLC claimed ownership of 6,973,166 units of Common Stock
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1752dINSIDER
SEC Form 3: BCTG Holdings, LLC claimed ownership of 6,988,450 units of Common Stock
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1752d13D/G
SEC Form SC 13D filed by BCTG Acquisition Corp.
SC 13D - Tango Therapeutics, Inc. (0001819133) (Subject)
1753d13D/G
SEC Form SC 13G filed by BCTG Acquisition Corp.
SC 13G - Tango Therapeutics, Inc. (0001819133) (Subject)
1753d13D/G
SEC Form SC 13D filed by BCTG Acquisition Corp.
SC 13D - Tango Therapeutics, Inc. (0001819133) (Subject)
1756dINSIDER
SEC Form 4 filed by Weber Barbara
4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1756dINSIDER
SEC Form 4 filed by Beckman Daniella
4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1756dINSIDER
SEC Form 4 filed by Huang Alan
4 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1759dSEC
SEC Form 8-K filed by BCTG Acquisition Corp.
8-K - Tango Therapeutics, Inc. (0001819133) (Filer)
1760dINSIDER
SEC Form 3: Weber Barbara claimed ownership of 1,367,592 units of Common Stock
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1760dINSIDER
SEC Form 3: Beckman Daniella claimed ownership of 63,867 units of Common Stock
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1760dINSIDER
SEC Form 3 filed by Peters Malte
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1760dINSIDER
SEC Form 3 filed by Rothenberg Mace
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1760dINSIDER
SEC Form 3 filed by Borisy Alexis
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1760dINSIDER
SEC Form 3 filed by Huber Reid M
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1760dINSIDER
SEC Form 3: Huang Alan claimed ownership of 135,887 units of Common Stock
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1760dINSIDER
SEC Form 3 filed by Calhoun Lesley Ann
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1760dINSIDER
SEC Form 3: Third Rock Ventures IV, L.P. claimed ownership of 19,363,975 units of Common Stock
3 - Tango Therapeutics, Inc. (0001819133) (Issuer)
1763dPR
Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies
– Business combination transaction with BCTG Acquisition Corp., a special purpose acquisition company sponsored by Boxer Capital, completed today – – Combined company Tango Therapeutics, Inc. will be listed on the Nasdaq Capital Market under ticker symbol "TNGX" – – Total expected cash position of approximately $515 million including gross proceeds from transaction totaling approximately $342 million, combining funds held in BCTG's trust account and PIPE financing once completed – CAMBRIDGE, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. ("Tango Therapeutics" or "Tango"), a biotechnology company committed to discovering and delivering the next generation of prec

BCTG FAQ

5 questions

Where does BCTG stock trade?
BCTG Acquisition Corp. (BCTG) is listed on NASDAQ.
What sector and industry is BCTG in?
BCTG Acquisition Corp. operates in the Finance sector, Business Services industry.
When did BCTG Acquisition Corp. go public?
BCTG Acquisition Corp. (BCTG) completed its IPO in 2020.
What companies are similar to BCTG?
Notable peers in the same industry include FLT (FleetCor Technologies Inc.), NVEI (Nuvei Corporation Subordinate Voting Shares), NLSN (Nielsen N.V.), STMP (Stamps.com Inc.), ENV (Envestnet Inc). Compare BCTG side-by-side with any of them on Quantisnow.
How can I track BCTG on Quantisnow?
Quantisnow aggregates BCTG Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BCTG to receive live email and push alerts on every new disclosure.